Each Friday the Global Corporate Venturing Deal Net rounds up the week’s smaller deals and tracks the emerging companies accessing corporate funds.
Axovant Sciences has spun out its small molecule team into a startup called Arvelle, which will develop an anti-epileptic drug after raising $100m in external funding.
Go-Jek is seeking bankers to work on a round already backed by JD.com, Google and Tencent that it now aims to close at $3bn.
